# NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation

> **NCT05073822** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University College, London**

## Conditions studied

- Renal Transplant Rejection
- Renal Transplant Infection

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT05073822
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-02-20
- **Primary completion:** 2027-02-20
- **Final completion:** 2027-02-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding not secured
- **Last updated:** 2023-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05073822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05073822, "NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05073822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*